MiniMed announces launch of IPO roadshow

GALWAY, Ireland, Feb. 24, 2026 /PRNewswire/ -- MiniMed Group, Inc. (MiniMed), a subsidiary of Medtronic plc (Medtronic) (NYSE: MDT), today announced that it has launched a roadshow for the initial public offering (IPO) of 28,000,000 shares of its common stock. The proposed offering is part of Medtronic's previously announced plan to separate its Diabetes business into an independent public company.

PRNewsWire • 12 hours ago

Medtronic's MiniMed aims to raise $784 million in US IPO

Medtronic's diabetes business MiniMed Group said on Tuesday it was aiming to raise as much as $784 million in its initial public offering in the United States.

Reuters • 14 hours ago

Dividend Medtech Giant Medtronic Is Built to Survive Any Market Crash

It isn't easy to find a healthcare company that regularly pays a generous dividend. It's even harder to find one with an annual raise streak approaching 50 years.

The Motley Fool • Feb 22, 2026

1 Reason I'd Buy Medtronic Stock and Never Sell

Medtronic is one of the world's largest medical device companies. Its dividend streak speaks volumes about the strength of its business.

The Motley Fool • Feb 22, 2026

The Only Healthcare Stock I Would Buy and Never Sell Is Medtronic

Medtronic is a large and diversified medical device company with a history of innovation. It has also consistently raised its dividend and is closing in now on Dividend King status.

The Motley Fool • Feb 21, 2026

Medtronic Analysts Cut Their Forecasts After Q3 Earnings

Medtronic PLC (NYSE: MDT) posted better-than-expected earnings for the third quarter on Tuesday.

Benzinga • Feb 18, 2026

Medtronic beats quarterly profit estimates on robust demand for heart devices

Medtronic surpassed Wall Street expectations for third-quarter profit on Tuesday, buoyed by strong demand for its heart devices and diabetes monitors.

Reuters • Feb 17, 2026

Medtronic Just Posted Its Best Quarter in 2.5 Years

Medtronic (NYSE: MDT) delivered its strongest enterprise revenue growth in 10 quarters, posting 8.7% reported growth (6.0% organic) for Q3 fiscal 2026.

24/7 Wall Street • Feb 17, 2026

Medtronic Profit Falls Despite Higher Revenue

Medtronic said profit fell in its fiscal third quarter as costs rose and the company invested more money into the business, offsetting higher revenue.

WSJ • Feb 17, 2026

Medtronic Posts Better-Than-Expected Earnings. Here's Why the Stock Is Falling.

Medtronic says it expects to take a $185 million hit from tariffs in the fiscal year.

Barrons • Feb 17, 2026